From: Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease
R-value | P-value | |
---|---|---|
Age | - 0.03 | 0.732 |
Gender | 0.119 | 0.175 |
Height | 0.044 | 0.646 |
Body weight | 0.009 | 0.925 |
Onset motor | - 0.23 | 0.02* |
Onset psychiatric | -0.23 | 0.095 |
Duration of disease | 0.18 | 0.035* |
UHDRS | 0.22 | 0.012* |
TFC | - 0.18 | 0.03* |
IS | -0.21 | 0.016* |
CAG not-expanded | 0.02 | 0.822 |
CAG expanded | 0.155 | 0.076 |
CAG Index | 0.18 | 0.04* |
Year to onset (YTO) Langbehn | 0.092 | 0.627 |
Shoulson scale | 0.15 | 0.087 |
Neuroleptic Intake | 0.149 | 0.088 |
SSRI intake | -0.63 | 0.473 |
Other Medication | 0.011 | 0.897 |
Smoking | -0.26 | 0.005** |
Infection | 0.27 | 0.002** |
Allergy | 0.097 | 0.268 |
Tapping dominant | -0.01 | 0.921 |
Tapping non-dominant | 0.0 | 0.998 |
Peg board dominant | 0.001 | 0.992 |
Peg board non-dominant | 0.088 | 0.992 |